ProCE Banner Activity

Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis

Slideset

Download these slides from a live symposium featuring expert pharmacist perspective guidance on best practices in the management of patients with myelofibrosis, with a focus on novel treatment options for patients with JAK inhibitor failure.

Released: May 23, 2023

Share

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from GSK.

GSK

Partners

Clinical Care Options, LLC 123

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

In partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)